Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06022965 · ClinicalTrials.gov registry record · NA

Telemedicine for Improvement of Care for Older Adults With Cancer in the Underserved Community, The GAIN-S Trial

A NA study of Malignant Solid Neoplasm and Hematopoietic and Lymphoid System Neoplasm, sponsored by City of Hope Medical Center.

Recruiting
Registry status
NA
Development phase
216
Enrollment target
3
Study locations

NCT06022965: Recruiting NA study of Malignant Solid Neoplasm and Hematopoietic and Lymphoid System Neoplasm, sponsored by City of Hope Medical Center.

NCT06022965 is a NA study of Malignant Solid Neoplasm and Hematopoietic and Lymphoid System Neoplasm that is actively recruiting participants, run by City of Hope Medical Center. The registered enrollment target is 216 participants, below the 1,140-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (81% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06022965, a NA study of Malignant Solid Neoplasm and Hematopoietic and Lymphoid System Neoplasm, is actively recruiting participants, sponsored by City of Hope Medical Center.

RECRUITING
Registry status
NA
Development phase
216 participants
Enrollment target
3
Study locations

Study Summary

This clinical trial evaluates whether geriatric assessment-driven interventions with supportive care (GAIN-S) using telemedicine can be used to identify areas of vulnerability (weakness) in older adults with cancer and guide interventions to assist the patient and the healthcare team in the underserved community. The majority of patients diagnosed with cancer are over age 65 years, yet most cancer treatments are developed and tested in a younger population. Therefore, older patients with cancer are less likely to be offered standard treatments because of the concern regarding side effects. Geriatric assessment (GA) is a multi-dimensional health assessment tool combining patient reported and objective (unbiased) results. There is no standard tool that can identify which older adults will be more likely to have side effects from cancer treatment. Telemedicine is a way to provide healthcare services (including consultations, education, care management and treatment) in which the health care provider is at a distant site. The goal of this project is to use telemedicine to identify areas of vulnerability/weakness in older adults with cancer using a patient assessment, and to identify the potential referrals to a multi-specialty team based on patient assessment results. Information gathered from this study may help researchers learn whether GAIN-S can be performed using telemedicine and lead to improvement in care for older adults compared to standard of care (SOC) in the underserved community.

Primary Outcome

Will be assessed using medical chart review. Chi-square test will be used to compare the proportions of AD completion between the two arms.

Interventions

  • OTHER Questionnaire Administration
  • OTHER Supportive Care
  • OTHER Best Practice
  • OTHER Comprehensive Geriatric Assessment
  • OTHER Electronic Health Record Review

Study Locations (3)

California

  • City of Hope Medical Center - Duarte
  • City of Hope Antelope Valley - Lancaster
  • City of Hope Upland - Upland

Trial Details

FieldValue
Enrollment Target 216 participants
Start Date 2023-07-24
Est. Completion 2027-01-24
Phase NA
City of Hope Medical Center

582 total trials

What NCT06022965 shows while recruiting

NCT06022965 is an interventional study that assigns participants to a tested intervention. The registered 216 participants enrollment target is mid-sized for trials with a published cap, below the 1,140-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (81% lower).

The record links to 2 conditions, with Malignant Solid Neoplasm appearing as the primary indexed condition, and to 5 interventions - of which Questionnaire Administration is the first listed.

NCT06022965 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06022965 about?

NCT06022965 is a clinical study titled "Telemedicine for Improvement of Care for Older Adults With Cancer in the Underserved Community, The GAIN-S Trial". This clinical trial evaluates whether geriatric assessment-driven interventions with supportive care (GAIN-S) using telemedicine can be used to identify areas of vulnerability (weakness) in older adults with cancer and guide interventions to assist the patient and the healthcare team in the underser...

What is the current status of trial NCT06022965?

This trial is currently recruiting. It is a NA study. The enrollment target is 216 participants. The study started on 2023-07-24. Estimated completion is 2027-01-24.

What conditions does trial NCT06022965 study?

This clinical trial studies the following conditions: Malignant Solid Neoplasm, Hematopoietic and Lymphoid System Neoplasm.

What interventions are being tested in trial NCT06022965?

The interventions under investigation include: Questionnaire Administration (OTHER), Supportive Care (OTHER), Best Practice (OTHER), Comprehensive Geriatric Assessment (OTHER), Electronic Health Record Review (OTHER).

Who is sponsoring clinical trial NCT06022965?

This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06022965 being conducted?

This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Malignant Solid Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06022965's enrollment target sits among peer trials

216 59th of 176 higher than 118 of 176 other Malignant Solid Neoplasm trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Malignant Solid Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02609685 · 216 participants · NA

    Active Surveillance of Papillary Thyroid Microcarcinoma

  • NCT04994873 · 216 participants · NA

    Skills to Enhance Positivity in Suicidal Youth

  • NCT05264779 · 216 participants · NA

    The Periviable GOALS Decision Support Tool

  • NCT05434130 · 216 participants · Phase 2

    Modulating Exercise Dosage to Improve Concussion Recovery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06022965, the US trial registry maintained by the National Library of Medicine. NCT06022965 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.